Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development
Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026
Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development
Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026